Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M164Revenue $M4.4Net Margin (%)-1,889.7Z-Score-1.0
Enterprise Value $M117EPS $-147.4Operating Margin %-1,862.7F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-1,889.7Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %0Quick Ratio14.6Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %0Current Ratio14.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-65.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-151.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M19.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ARGS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pharmstandard International S.10% Owner 2014-02-12Buy1,275,000$812.75view
Underdown Brian J.Director, 10% Owner 2014-02-12Buy40,497$812.75view
Cooperatieve AAC LS U.A.10% Owner 2014-02-12Buy36,416$812.75view
Birner HubertDirector, 10% Owner 2014-02-12Buy39,873$812.75view
van Deventer SanderDirector, 10% Owner 2014-02-12Buy36,416$812.75view
Mizuho Capital No. 3 Limited P10% Owner 2014-02-06Sell0$012.75view
Kyowa Hakko Kirin Co Ltd10% Owner 2014-02-06Sell0$012.75view
TFG USA, LLC10% Owner 2014-02-06Sell0$012.75view

Press Releases about ARGS :

    Quarterly/Annual Reports about ARGS:

      News about ARGS:

      Articles On GuruFocus.com
      Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

      More From Other Websites
      8:42 am Argos Therapeutics announces that an update on its Phase 3 ADAPT clinical trial of AGS-003... Feb 27 2015
      Argos Therapeutics Announces Update on Phase 3 ADAPT Trial to be Presented During 2015 ASCO... Feb 27 2015
      Argos Therapeutics Announces Update on Phase 3 ADAPT Trial to be Presented During 2015 ASCO... Feb 27 2015
      Coverage initiated on Argos Therapeutics by MLV & Co Feb 25 2015
      Joan C. Winterbottom Joins Argos Therapeutics as Chief Human Resources Officer Feb 24 2015
      Joan C. Winterbottom Joins Argos Therapeutics as Chief Human Resources Officer Feb 24 2015
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Feb 20 2015
      Argos Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference Feb 02 2015
      Argos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015 Jan 23 2015
      Argos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015 Jan 23 2015
      Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit... Jan 22 2015
      Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit... Jan 22 2015
      Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference... Jan 20 2015
      Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference... Jan 20 2015
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 09 2015
      Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized... Jan 09 2015
      Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized... Jan 09 2015
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 07 2015
      Argos Therapeutics to Present at Biotech Showcase 2015 Jan 06 2015
      Argos Therapeutics to Present at Biotech Showcase 2015 Jan 06 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK